首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1477281

缺鐵性貧血治療市場，依藥物類型、劑型、配銷通路、地理位置

Iron Deficiency Anemia Treatment Market, By Drug Type, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2024年04月04日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球缺鐵性貧血治療市值為121億美元，預計2031年將達216億美元，2024年至2031年年複合成長率（CAGR）為8.6%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	121 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	8.60%	2031 年價值預測：	216 億美元

圖 1. 2024 年缺鐵性貧血治療市佔率 (%)（依地區）

據世界衛生組織稱，缺鐵性貧血是一種非常常見的營養缺乏症，影響全球超過十億人。當身體沒有足夠的鐵來產生血紅蛋白時，就會發生這種情況，血紅蛋白是紅血球中的一種必需蛋白質，可將氧氣輸送到全身。症狀各不相同，從疲勞、虛弱到頭痛、頭暈和呼吸困難。如果不及時治療，它可能會成為一種嚴重的健康狀況，並對身體和認知發展產生負面影響，尤其是嬰兒、幼兒和婦女。隨著副作用更小、療效更高的新型口服和注射藥物的出現，全球缺鐵性貧血治療市場正在強勁成長。

市場動態：

全球缺鐵性貧血治療市場的成長是由全球缺鐵性貧血盛行率不斷上升所推動的，特別是在兒童和婦女中。導致缺鐵性貧血病例增加的關鍵因素包括飲食中富含鐵的食物攝取不足、月經期間失血和寄生蟲感染。據世界衛生組織稱，全球約 40% 的孕婦患有貧血，預計將推動對有效治療藥物的需求。領先企業開發新藥是該領域的重大成長機會。然而，在發展中經濟體中，替代治療方案（包括補充劑和植物療法）的可用性可能會在不久的將來在一定程度上抑制現代藥物的商業應用。

研究的主要特點：

該報告對全球缺鐵性貧血治療市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數介紹了全球缺鐵性貧血治療市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球缺鐵性貧血治療市場迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
利害關係人可以透過用於分析全球缺鐵性貧血治療市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 9 章：競爭格局

公司簡介
- AdvaCare Pharma
- Otsuka Pharmaceutical Co., Ltd.
- Sanofi
- Emcure Pharmaceuticals
- Wellona Pharma
- SiNi Pharma Pvt Ltd
- Sun Pharmaceutical Industries Ltd.
- Zydus Group
- Akebia Therapeutics.
- Rockwell Medical, Inc.
- AbbVie Inc.
- Pfizer, Inc.
- Velnex Medicare
- PHAEDRUS LIFE SCIENCE PVT. LTD.
- Inopha International Co, Limited
- PharmaNutra SpA
- Pharmascience Inc.
- American Regent, Inc.

第 10 章：分析師建議

命運之輪
分析師觀點
連貫的機會圖

第 11 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6855

Global iron deficiency anemia treatment market is estimated to be valued at US$ 12.1 Bn in 2024 and is expected to reach US$ 21.6 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 12.1 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	8.60%	2031 Value Projection:	US$ 21.6 Bn

Figure 1. Iron Deficiency Anemia Treatment Market Share (%), By Region, 2024

Iron Deficiency Anemia Treatment Market - IMG1

Iron deficiency anemia is a very common nutritional deficiency that affects over a billion people worldwide, according to the World Health Organization. It occurs when the body does not have enough iron to produce hemoglobin, an essential protein in red blood cells that carries oxygen throughout the body. Symptoms can vary from fatigue and weakness to headaches, dizziness, and breathlessness. Left untreated, it can be a serious health condition and negatively impact physical and cognitive development especially in infants, young children and women. Global iron deficiency anemia treatment market is witnessing strong growth with emergence of new oral and injectable drugs having less side effects and higher efficacy.

Market Dynamics:

Global iron deficiency anemia treatment market growth is driven by growing prevalence of the condition globally especially among children and women. Key factors contributing to rising cases of iron deficiency anemia include poor dietary intake of iron-rich foods, blood loss during menstruation, and parasitic infections. According to WHO, approximately 40% of pregnant women worldwide suffer from anemia, which is expected to propel demand for effective therapeutic drugs. Development of novel drugs by leading players is a significant growth opportunity in this space. However, availability of alternative treatment options including supplements and plant-based remedies in developing economies can restrain commercial uptake of modern medications to some extent in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global iron deficiency anemia treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global iron deficiency anemia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes AdvaCare Pharma, Otsuka Pharmaceutical Co., Ltd., Sanofi, Emcure Pharmaceuticals, Wellona Pharma, SiNi Pharma Pvt Ltd, Sun Pharmaceutical Industries Ltd., Zydus Group, Akebia Therapeutics., Rockwell Medical, Inc., AbbVie Inc., Pfizer, Inc., Velnex Medicare, PHAEDRUS LIFE SCIENCE PVT. LTD., Inopha International Co, Limited, PharmaNutra S.p.A., Pharmascience Inc., and American Regent, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global iron deficiency anemia treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global iron deficiency anemia treatment market

Detailed Segmentation-

Drug Type:
- Ferrous Sulfate
- Ferrous Gluconate
- Ferrous Fumerate
- Ferric Hydroxide
- Others
Dosage Form:
- Tablets
- Capsules
- Liquid
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AdvaCare Pharma
- Otsuka Pharmaceutical Co., Ltd.
- Sanofi
- Emcure Pharmaceuticals
- Wellona Pharma
- SiNi Pharma Pvt Ltd
- Sun Pharmaceutical Industries Ltd.
- Zydus Group
- Akebia Therapeutics.
- Rockwell Medical, Inc.
- AbbVie Inc.
- Pfizer, Inc.
- Velnex Medicare
- PHAEDRUS LIFE SCIENCE PVT. LTD.
- Inopha International Co, Limited
- PharmaNutra S.p.A.
- Pharmascience Inc.
- American Regent, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Reimbursement scenario
Regulatory Scenario
Pricing Analysis
Brand Analysis
PEST Analysis

4. Global Iron Deficiency Anemia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Iron Deficiency Anemia Treatment Market, By Drug Type, 2019 - 2031, (US$ Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Ferrous Sulfate
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Ferrous Gluconate
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Ferrous Fumerate
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Ferric Hydroxide
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

6. Global Iron Deficiency Anemia Treatment Market, By Dosage Form, 2019 - 2031, (US$ Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Capsules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

7. Global Iron Deficiency Anemia Treatment Market, By Distribution Channel, 2019 - 2031, (US$ Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

8. Global Iron Deficiency Anemia Treatment Market, By Region, 2019 - 2031, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- AdvaCare Pharma *
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Otsuka Pharmaceutical Co., Ltd.
- Sanofi
- Emcure Pharmaceuticals
- Wellona Pharma
- SiNi Pharma Pvt Ltd
- Sun Pharmaceutical Industries Ltd.
- Zydus Group
- Akebia Therapeutics.
- Rockwell Medical, Inc.
- AbbVie Inc.
- Pfizer, Inc.
- Velnex Medicare
- PHAEDRUS LIFE SCIENCE PVT. LTD.
- Inopha International Co, Limited
- PharmaNutra S.p.A.
- Pharmascience Inc.
- American Regent, Inc.